HealthCor Management’s Hyperfine HYPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.26M Buy
3,880,900
+1,131,500
+41% +$1.03M 2.99% 5
2022
Q3
$2.23M Hold
2,749,400
0.28% 50
2022
Q2
$6.13M Buy
2,749,400
+999,400
+57% +$2.94M 0.62% 36
2022
Q1
$6.2M Buy
1,750,000
+1,058,350
+153% +$4.37M 0.41% 43
2021
Q4
$5.01M Buy
+691,650
New +$5.48M 0.27% 49

Other funds holding HYPR

HealthCor Management's HYPR Position: Q4 2022 in Review

HealthCor Management increased its Hyperfine (HYPR) stake by 41% in Q4 2022, buying an estimated $1.03M and bringing the position to 3,880,900 shares worth $3.26M. The position accounts for 2.99% of the portfolio, ranked #5.

HealthCor Management first reported a position in HYPR in Q4 2021 and has held it in 5 quarters since. The position peaked at $6.2M in Q1 2022. 39 funds tracked by Wall St. Rank hold HYPR as of Q4 2022.

  • HealthCor Management held 3,880,900 shares of Hyperfine worth $3.26M as of Q4 2022.
  • HealthCor Management bought 1,131,500 Hyperfine shares in Q4 2022, an estimated $1.03M.
  • Hyperfine made up 2.99% of HealthCor Management's portfolio in Q4 2022, its #5 holding.
  • HealthCor Management first reported a position in Hyperfine in Q4 2021 and has held it in 5 quarters since.
  • HealthCor Management's Hyperfine position peaked at $6.2M in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Hyperfine as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.